TELUS Offers Value With AI And Fiber Tailwinds

TELUS is presented as undervalued with a 9.7% dividend yield and a share price near its 52-week low, which supports a Buy view. The thesis is driven by lower capital intensity, free cash flow growth, and AI-enabling opportunities, while TELUS Health is posting double-digit revenue and EBITDA growth. The note is constructive but largely reiterates a valuation and growth case rather than introducing a major new catalyst.

Analysis

The market is likely still valuing TU as a slow-growth yield proxy, but the real opportunity is in the mix shift: if management can sustain lower capex while monetizing higher-margin digital/health services, equity value should re-rate because incremental EBITDA is no longer being consumed by network reinvestment. That matters more in a higher-rate regime, where a 9.7% payout competes with bond yields only if the dividend is perceived as durable and not being financed by asset decay.

Second-order beneficiaries are the infrastructure and software vendors that enable this lighter-capex model, while legacy telecom peers with heavier build requirements face a tougher comp if TU proves it can grow FCF faster than revenue. The AI angle is also less about headline adoption and more about embedded productivity: even modest improvements in customer service, sales conversion, and churn can meaningfully lift telecom margins because the base business is high-fixed-cost and operational leverage is strong.

The key risk is that the yield is signaling skepticism, not value, and telecom reratings can take quarters rather than days. If execution slips on health or AI monetization, the stock can remain trapped near book-value optics despite cheap cash flow multiples; rising refinancing costs or a dividend-policy surprise would be the fastest ways to break the thesis. Near term, watch for any evidence that free-cash-flow conversion is inflecting before the market will pay up for the growth story.

Key Decisions for Investors

• Add TU on weakness over the next 2-6 weeks, targeting a 12-month total return profile driven by yield plus multiple expansion; downside is limited if the dividend is maintained, but thesis breaks if FCF guidance softens.
• Use a long TU / short a higher-capex telecom peer basket as a relative-value trade for 3-9 months; the spread should widen if TU sustains lower reinvestment intensity and better cash conversion.
• Buy TU call spreads 6-12 months out to express upside from a rerating without overpaying for yield-driven stagnation; attractive if you expect the market to reprice the stock before the next annual cycle.
• For income portfolios, initiate a starter position but cap sizing until the next quarterly update confirms dividend coverage and health/AI contribution to EBITDA; this is a ‘prove-it’ yield, not a full conviction bond substitute.
• If TU rallies sharply on the narrative alone, fade part of the move and wait for a better entry unless capex and FCF data confirm the operating leverage story.